GeneDx Holdings

Update in progress

WGS (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

GeneDx Holdings Corp is a genomics company that provides genetic testing services, with a primary emphasis on pediatric and rare disease diagnostics. It focuses on whole exome and whole genome sequencing, along with data and information services. The company also develops an AI-based platform for next-generation sequencing analysis, interpretation, and clinical reporting for rare diseases, hereditary risk, and cancer. Founded in 2000, based in Stamford, Connecticut.

Company score

Sentiment: -0.20; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.09; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.24; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.02; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.11; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive